Inventor
Masamichi Koike
Inventor
Tokyo, JP
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C12NMicroorganisms or enzymes5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
G06FElectric digital data processing1%
H04LTransmission of digital information, e.g. telegraphic communication1%
PatentTitleYear
10,590,203Human CDR-grafted antibody and antibody fragment thereof202010,131,711Human CDR-grafted antibody and antibody fragment thereof20189,051,371'Human CDR-grafted antibody and antibody fragment thereof'20158,900,584'Human CDR-grafted antibody and antibody fragment thereof'20148,804,963'Computer readable medium storing key generating program, computer readable medium storing key recording program, key generating device, PKI card, key recording system, key generating method and key recording method'20148,363,944'Reading a print image including document and code image for signature verification'20138,143,058'Human CDR-grafted antibody and antibody fragment thereof'20127,842,797'Human CDR-grafted antibody and antibody fragment thereof'20107,504,104'Human CDR-grafted antibody and antibody fragment thereof'20097,404,953'Methods using eosinophil-specific apoptosis inducer'20087,238,354'Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain'20077,179,464'Method of treatment by administering an antibody to human interleukin-5 receptor α chain'20076,872,392'Humanized antibodies'20056,538,111'Antibody against human interleukin-5 receptor alpha chain'20036,423,511'Humanized antibodies'20026,042,828'Humanized antibodies to ganglioside GM.sub.2'20006,018,032'Antibody against human interleukin-5-receptor .alpha. chain'20005,939,532'Humanized antibodies to ganglioside GM.sub.2'19995,874,255'DNA encoding humanized antibodies specific for the ganglioside GM.sub.2'19995,830,470'Humanized antibodies to ganglioside GM.sub.2'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2009Patents assigned to KYOWA HAKKO KOGYO KK (12)· patent assignee history
1998–2008Based in Tokyo, JP· patent location history
2007Based in Naka-machi, JP· patent location history
2009–2020Based in Machida, JP· patent location history
2010–2020Patents assigned to KYOWA HAKKO KIRIN CO LTD (6)· patent assignee history
2012–2014Patents assigned to KOIKE MASAMICHI (3)· patent assignee history
2012Patents assigned to HOSAKA EMI (1)· patent assignee history
2013–2014Patents assigned to FUJI XEROX CO LTD (2)· patent assignee history
2013Based in Kawasaki, JP· patent location history
2014Based in Kanagawa, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KYOWA HAKKO KOGYO KK | 12 | 1998–2009 |
| KYOWA HAKKO KIRIN CO LTD | 6 | 2010–2020 |
| KOIKE MASAMICHIself | 3 | 2012–2014 |
| FUJI XEROX CO LTD | 2 | 2013–2014 |
| HOSAKA EMI | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tokyo, JP | 10 | 1998–2008 |
| Machida, JP | 7 | 2009–2020 |
| Kanagawa, JP | 1 | 2014 |
| Kawasaki, JP | 1 | 2013 |
| Naka-machi, JP | 1 | 2007 |